Markets:

Overview

News

Currencies

International

Treasuries

Medicus Pharma Ltd. - Common Stock (NQ:MDCX)

0.2716 +0.0090 (+3.43%)

Streaming Delayed Price Updated: 10:49 AM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medicus Pharma Ltd. - Common Stock

< Previous 1 2 3 4 5 Next >

Nasdaq Down 100 Points; Chicago PMI Dips In May ↗

May 30, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Friday's session. ↗

May 30, 2025

Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

Top movers in Friday's pre-market session ↗

May 30, 2025

The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket ↗

May 30, 2025

Via Benzinga

Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

May 30, 2025

Dr. Raza Bokhari, Company’s Former CEO, Paid $2.35 Million USD in Non-Dilutive Cash to Cover Legal and Other Costs Determined in the Arbitral Award Over the Past 4 Years

From Quantum BioPharma

Via GlobeNewswire

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

May 28, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Top movers analysis in the middle of the day on 2025-05-28: top gainers and losers in today's session. ↗

May 28, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Medicus Pharma's 'Savvy' Antev Deal De-Risks Pipeline Expansion, Enhances Near-Commercial Portfolio ↗

May 12, 2025

Medicus to acquire Antev and expand into urology with Teverelix while reporting positive data in its Phase 2 skin cancer trial for D-MNA.

Via Benzinga

Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday ↗

May 12, 2025

Via Benzinga

This Millrose Properties Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

April 14, 2025

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.